Australia's Cyclopharm rises on additional purchase orders from US

Cyclopharm

01/04/2025 01:53

** Shares of Cyclopharm CYC.AX rise 4.4% to A$1.20, their highest level since March 27

** Radiopharmaceutical co receives an additional installation purchase order from another U.S. Department of Veterans Affairs hospital

** Since commercial sales of Technegas commenced in the United States last year, sales receipts have now exceeded $1 mln - company

** Stock rose as much as 4.8% earlier in the day, its biggest intraday gain since March 14

** Stock down 24.3% this year, including the day's move

 (Reporting by Shivangi Lahiri in Bengaluru)

 ((shivangi.lahiri@thomsonreuters.com;))